In addition, elevated SHP-1 expression has been associated with several types of tumors, such as epithelial ovarian cancers (63) and high-grade breast cancers (64), suggesting SHP-1 as a potential therapeutic target. The gene discussed is PTPN6; the disease is breast cancer.